Dear viewers , this presentation includes all information about Ebola virus , like introduction,symptoms,preventions,origin,etc.I hope you all improve your knowledge by going through this presentation.
The document provides information about a biology presentation on the Ebola virus given by Sidra Bibi. It discusses what Ebola virus is, how it is transmitted in the human body, the types of diseases it causes, treatment and precautions. It notes that Ebola virus kills up to 90% of infected people and is transmitted through contact with infected animals or humans. The presentation covers Ebola's history, symptoms, treatment involving supportive care, and prevention through safe practices like proper hygiene and protective equipment.
The document provides information on the Ebola virus. It discusses that Ebola virus disease first appeared in 1976 in simultaneous outbreaks in Sudan and Zaire. It belongs to the filovirus family and species Zaire ebolavirus which caused the 2014 West African outbreak. The virus infects and kills its host efficiently by attacking the lymph nodes and bloodstream. While there is no proven cure, several vaccine candidates and antiviral treatments are being studied.
This document summarizes Ebola virus disease. It classifies Ebola virus as a negative-sense single-stranded RNA virus in the Filoviridae family. It describes the five species of Ebola virus and their origins and fatality rates. It discusses the virus structure, mechanisms of infection transmission through contact with body fluids or infected animals. Symptoms include fever and bleeding, and diagnosis involves antigen and PCR testing. There is currently no approved vaccine or treatment, though experimental drugs have been used.
The document summarizes information about the Ebola virus. It is a severe infectious and often fatal disease that originated in Africa near the Ebola River. Ebola causes bleeding inside and outside the body and has a high fatality rate. While there is no licensed treatment, supportive care is provided to patients. A vaccine was approved in 2019 to help prevent the spread of the Zaire species of Ebola virus. Proper prevention, control methods, and vaccination are important to address future Ebola outbreaks.
The Ebola virus first appeared in 1976 near the Ebola River in Africa and is a severe and often fatal infectious disease in humans and primates. It causes bleeding inside and outside the body and is transmitted through contact with bodily fluids of infected animals or people. The virus lives in bats and other animals in Africa and people can contract it by handling or eating sick animals. There is no licensed specific treatment for Ebola, though supportive care such as rehydration is given and new drug therapies are being evaluated.
The document discusses Ebola virus disease (EVD), also known as Ebola hemorrhagic fever (EHF). It was first discovered in 1976 near the Ebola River in the Democratic Republic of Congo. Fruit bats are believed to be the natural reservoir of the Ebola virus and can spread it to humans through contact with their blood/body fluids. Ebola causes severe hemorrhagic fever in humans and non-human primates with symptoms like fever, muscle pain and bleeding, often leading to death within 6-16 days. The 2014-2016 outbreak in West Africa was the largest on record, spreading from Guinea to Liberia and Sierra Leone. There is currently no approved vaccine or
The document provides information on Ebola virus, including:
1. Ebola virus is classified in the genus Ebolavirus and family Filoviridae. There are 5 species that cause disease in humans, with Zaire ebolavirus having the highest fatality rate of up to 90%.
2. Ebola virus disease symptoms start suddenly and include fever, muscle pain, and headaches. Later symptoms include vomiting, diarrhea, and internal/external bleeding.
3. The virus is transmitted through contact with infected body fluids and tissue. Bats are believed to be the natural reservoir of the virus. There is no approved vaccine or treatment, though supportive care can increase survival.
Ebola gets introduced into the human population through close contact with the blood, secretions, organs or other bodily fluids of infected animals. Follow the preventive measures for betterment.
The document provides information about a biology presentation on the Ebola virus given by Sidra Bibi. It discusses what Ebola virus is, how it is transmitted in the human body, the types of diseases it causes, treatment and precautions. It notes that Ebola virus kills up to 90% of infected people and is transmitted through contact with infected animals or humans. The presentation covers Ebola's history, symptoms, treatment involving supportive care, and prevention through safe practices like proper hygiene and protective equipment.
The document provides information on the Ebola virus. It discusses that Ebola virus disease first appeared in 1976 in simultaneous outbreaks in Sudan and Zaire. It belongs to the filovirus family and species Zaire ebolavirus which caused the 2014 West African outbreak. The virus infects and kills its host efficiently by attacking the lymph nodes and bloodstream. While there is no proven cure, several vaccine candidates and antiviral treatments are being studied.
This document summarizes Ebola virus disease. It classifies Ebola virus as a negative-sense single-stranded RNA virus in the Filoviridae family. It describes the five species of Ebola virus and their origins and fatality rates. It discusses the virus structure, mechanisms of infection transmission through contact with body fluids or infected animals. Symptoms include fever and bleeding, and diagnosis involves antigen and PCR testing. There is currently no approved vaccine or treatment, though experimental drugs have been used.
The document summarizes information about the Ebola virus. It is a severe infectious and often fatal disease that originated in Africa near the Ebola River. Ebola causes bleeding inside and outside the body and has a high fatality rate. While there is no licensed treatment, supportive care is provided to patients. A vaccine was approved in 2019 to help prevent the spread of the Zaire species of Ebola virus. Proper prevention, control methods, and vaccination are important to address future Ebola outbreaks.
The Ebola virus first appeared in 1976 near the Ebola River in Africa and is a severe and often fatal infectious disease in humans and primates. It causes bleeding inside and outside the body and is transmitted through contact with bodily fluids of infected animals or people. The virus lives in bats and other animals in Africa and people can contract it by handling or eating sick animals. There is no licensed specific treatment for Ebola, though supportive care such as rehydration is given and new drug therapies are being evaluated.
The document discusses Ebola virus disease (EVD), also known as Ebola hemorrhagic fever (EHF). It was first discovered in 1976 near the Ebola River in the Democratic Republic of Congo. Fruit bats are believed to be the natural reservoir of the Ebola virus and can spread it to humans through contact with their blood/body fluids. Ebola causes severe hemorrhagic fever in humans and non-human primates with symptoms like fever, muscle pain and bleeding, often leading to death within 6-16 days. The 2014-2016 outbreak in West Africa was the largest on record, spreading from Guinea to Liberia and Sierra Leone. There is currently no approved vaccine or
The document provides information on Ebola virus, including:
1. Ebola virus is classified in the genus Ebolavirus and family Filoviridae. There are 5 species that cause disease in humans, with Zaire ebolavirus having the highest fatality rate of up to 90%.
2. Ebola virus disease symptoms start suddenly and include fever, muscle pain, and headaches. Later symptoms include vomiting, diarrhea, and internal/external bleeding.
3. The virus is transmitted through contact with infected body fluids and tissue. Bats are believed to be the natural reservoir of the virus. There is no approved vaccine or treatment, though supportive care can increase survival.
Ebola gets introduced into the human population through close contact with the blood, secretions, organs or other bodily fluids of infected animals. Follow the preventive measures for betterment.
Ebola virus disease first appeared in 1976 in two outbreaks in central Africa. The current west Africa outbreak beginning in 2014 is the largest on record. Ebola virus is a rare but deadly virus that causes bleeding and damages organs and the immune system. It spreads through contact with infected animals like bats or non-human primates, or through contact with a sick or dead human's bodily fluids. Health care providers and family members in close contact with patients have the highest risk of infection. While there is no approved vaccine or treatment, experimental treatments aim to manage symptoms and replace fluids and blood.
Ebola virus disease is a severe and often fatal illness in humans that is transmitted through contact with infected wildlife or humans. There are 5 species of Ebola virus, and the average fatality rate is around 50%. The virus carries a negative-sense RNA genome and has cylindrical virions that infect hosts and spread until killing the host. The first Ebola outbreaks occurred in 1976 in Sudan and Democratic Republic of Congo. While there is no proven treatment, supportive care such as rehydration can improve survival rates.
Ebola hemorrhagic fever is a often-fatal viral disease that affects humans and nonhuman primates. It was first discovered in 1976 near the Ebola River in the Democratic Republic of Congo. There are 5 distinct sub-species of the Ebola virus. The natural reservoir of the virus is unknown, but it is believed to be animal-borne and native to Africa. Early symptoms include fever, headache, and muscle pain. Late stage symptoms are more severe and include internal and external bleeding. The virus disables a human protein called tetherin that normally prevents virus spread, allowing the virus to efficiently spread from cell to cell. There is no approved vaccine yet for Ebola virus, but research is
Ebola Virus was first recognized in 1976 near Congo in Africa. The Ebola Virus spread throughout West Africa in the year 2014-2016. In 2016, Ebola Virus infection was able to reduce due to the found of Vaccine.
Ebolavirus is a filovirus that causes severe hemorrhagic fever in humans and non-human primates. It is transmitted through contact with bodily fluids and targets endothelial cells. Initial symptoms are nonspecific but progress to vomiting, diarrhea and external bleeding. The incubation period is 2-21 days and fatality rates vary between virus strains but average around 50-90%. Diagnosis is through ELISA tests detecting antibodies. While there is no approved vaccine or treatment, supportive care improving hydration and nutrition can increase survival rates.
Ebola virus causes a severe hemorrhagic fever with high fatality rates. It was first identified in 1976 and is transmitted through contact with infected body fluids. Symptoms include fever, muscle pain and bleeding. While there is no approved vaccine or treatment, recovery depends on supportive care. Outbreaks have occurred in central Africa and prevention focuses on isolation, protective equipment for healthcare workers, and safe burials.
The document discusses Ebola virus disease (EVD), also known as Ebola hemorrhagic fever. It first appeared in Africa in 1976 and causes severe bleeding and organ failure in humans and nonhuman primates. The virus spreads through direct contact with body fluids of infected individuals or contaminated environments. While there is no approved vaccine or treatment, prevention focuses on isolation of patients, medical staff training in infection control, safe burials, and avoiding contact with high-risk animals like bats that may carry the virus. The document provides details on the virus's pathogenesis, symptoms, subtypes, transmission methods, and the challenges it poses given its rapid multiplication and ability to evade immune responses.
Ebola Hemorrhagic Fever is a severe disease caused by the Ebola virus which originated in Africa. It spreads through contact with bodily fluids of infected humans or animals. Initial symptoms include fever, headache and muscle pain. Later symptoms include vomiting, diarrhea and internal/external bleeding. There is no approved vaccine or treatment, with supportive care being the standard. Prevention focuses on avoiding contact with infected patients and wildlife.
About EBOLA, Origin, types, Causes,Mode of Transmission, Symptoms, Treatment, Means to Help to Ease Symptoms, Teats & Diagnosis, Treatment & Drugs, Prevention, Vaccine Development,
Ebola virus is suspected to be zoonotic, transmitted from bats and primates to humans through contact with bodily fluids. It infects macrophages, causing them to release cytokines that produce symptoms like fever and vascular problems. This leads to small blood clots, disruption of coagulation, bleeding, and multi-organ failure. The incubation period is 2-21 days on average. Laboratory diagnosis involves non-specific tests like leukopenia and elevated liver enzymes, as well as specific tests detecting the virus's RNA, proteins, or antibodies.
Description about recent outbreak of Ebola virus in West African countries with history, pathogenesis, clinical signs and prevention measures of Filoviruses are presented in comprehensive manner.
This document summarizes key information about filoviruses Marburg virus and Ebola virus. It describes their family, genera, species, genome structure, morphology, replication, pathogenesis, outbreak history, transmission, vaccine development, recovery mechanisms, and suspected bat reservoirs. Major points include that filoviruses cause hemorrhagic fever outbreaks in Africa with high fatality rates through close contact transmission, and while experimental vaccines exist, recovery mechanisms remain unknown.
This document summarizes key information about the Ebola virus. It describes Ebola as an enveloped RNA virus that originated in Africa and is typically transmitted between humans through direct contact with bodily fluids of infected individuals. While fruit bats are believed to be the natural reservoir, humans can also contract the virus through contact with infected wildlife. The virus causes severe disease by directly infecting tissues and triggering immune dysregulation, hypovolemia, coagulopathy, and ultimately multi-organ failure. Mortality rates are high, ranging from 25-90% depending on the strain.
- Filoviruses like Ebola and Marburg viruses cause severe hemorrhagic fever in humans and non-human primates with high fatality rates. Though outbreaks are frequent, the natural reservoir of Ebola virus remains unclear.
- There are five species of Ebola virus (Zaire, Sudan, Reston, Ivory Coast, Bundibugyo) and Marburg virus. Ebola Zaire has the highest fatality rate of up to 90% while E. Reston has not caused death in humans.
- Transmission occurs through contact with bodily fluids of infected humans or animals. There is no approved treatment, though supportive care, vaccination research, and
Ebola virus disease is a severe and often fatal illness in humans caused by Ebola virus. The virus is transmitted through contact with infected wildlife like fruit bats or with bodily fluids of infected humans. Symptoms include sudden onset of fever, muscle pain and bleeding. While there is no approved vaccine, treatment focuses on rehydration and supportive care. Fruit bats are considered the natural reservoir of the virus in Africa.
This document provides information about Ebola virus disease, including its transmission, pathogenesis, symptoms, treatment, and prevention. Ebola is a zoonotic virus transmitted through contact with infected body fluids that causes hemorrhagic fever. It enters the body through mucous membranes or breaks in the skin. The virus then infects macrophages and endothelial cells, evading the immune system and causing systemic symptoms like fever, vomiting, and bleeding due to coagulopathy. Current treatment is supportive only, focusing on fluid replacement and symptom management.
Ebola virus disease is a severe and often fatal illness in humans that was first identified in 1976. The virus spreads through direct contact with body fluids from infected humans or animals. Early symptoms include fever, fatigue, and muscle pain that can progress to vomiting, diarrhea and internal bleeding. While there is no licensed treatment, supportive care such as rehydration can improve survival. The 2014-2015 outbreak in West Africa was the largest in history, resulting in over 23,000 cases and 9,600 deaths across multiple countries. Controlling the outbreak requires community engagement along with safe practices in healthcare settings and burials.
The document provides information on Ebola virus, including its history, outbreaks, transmission, symptoms, diagnosis and potential treatments. It discusses how Ebola was first identified in 1976 near the Ebola River in Africa. It causes severe hemorrhagic fever in humans with high mortality. While fruit bats are suspected to be the natural reservoir, transmission occurs between humans via contact with bodily fluids. Current efforts are focused on supportive care and experimental therapies like monoclonal antibodies, antivirals and immunomodulators until a vaccine is developed.
Ebola virus disease is a severe and often fatal disease caused by the Ebola virus. It first appeared in 1976 in simultaneous outbreaks in the Democratic Republic of Congo and Sudan. Ebola is categorized as a Category A bioterrorism agent due to its high potential to be used as a biological weapon because it can easily spread between humans and causes severe illness with high mortality rates. Signs and symptoms include fever, muscle pain, vomiting and bleeding. There is currently no cure, so treatment focuses on isolation, intensive care, and surveillance to prevent further spread.
Ebola virus disease first appeared in 1976 in two outbreaks in central Africa. The current west Africa outbreak beginning in 2014 is the largest on record. Ebola virus is a rare but deadly virus that causes bleeding and damages organs and the immune system. It spreads through contact with infected animals like bats or non-human primates, or through contact with a sick or dead human's bodily fluids. Health care providers and family members in close contact with patients have the highest risk of infection. While there is no approved vaccine or treatment, experimental treatments aim to manage symptoms and replace fluids and blood.
Ebola virus disease is a severe and often fatal illness in humans that is transmitted through contact with infected wildlife or humans. There are 5 species of Ebola virus, and the average fatality rate is around 50%. The virus carries a negative-sense RNA genome and has cylindrical virions that infect hosts and spread until killing the host. The first Ebola outbreaks occurred in 1976 in Sudan and Democratic Republic of Congo. While there is no proven treatment, supportive care such as rehydration can improve survival rates.
Ebola hemorrhagic fever is a often-fatal viral disease that affects humans and nonhuman primates. It was first discovered in 1976 near the Ebola River in the Democratic Republic of Congo. There are 5 distinct sub-species of the Ebola virus. The natural reservoir of the virus is unknown, but it is believed to be animal-borne and native to Africa. Early symptoms include fever, headache, and muscle pain. Late stage symptoms are more severe and include internal and external bleeding. The virus disables a human protein called tetherin that normally prevents virus spread, allowing the virus to efficiently spread from cell to cell. There is no approved vaccine yet for Ebola virus, but research is
Ebola Virus was first recognized in 1976 near Congo in Africa. The Ebola Virus spread throughout West Africa in the year 2014-2016. In 2016, Ebola Virus infection was able to reduce due to the found of Vaccine.
Ebolavirus is a filovirus that causes severe hemorrhagic fever in humans and non-human primates. It is transmitted through contact with bodily fluids and targets endothelial cells. Initial symptoms are nonspecific but progress to vomiting, diarrhea and external bleeding. The incubation period is 2-21 days and fatality rates vary between virus strains but average around 50-90%. Diagnosis is through ELISA tests detecting antibodies. While there is no approved vaccine or treatment, supportive care improving hydration and nutrition can increase survival rates.
Ebola virus causes a severe hemorrhagic fever with high fatality rates. It was first identified in 1976 and is transmitted through contact with infected body fluids. Symptoms include fever, muscle pain and bleeding. While there is no approved vaccine or treatment, recovery depends on supportive care. Outbreaks have occurred in central Africa and prevention focuses on isolation, protective equipment for healthcare workers, and safe burials.
The document discusses Ebola virus disease (EVD), also known as Ebola hemorrhagic fever. It first appeared in Africa in 1976 and causes severe bleeding and organ failure in humans and nonhuman primates. The virus spreads through direct contact with body fluids of infected individuals or contaminated environments. While there is no approved vaccine or treatment, prevention focuses on isolation of patients, medical staff training in infection control, safe burials, and avoiding contact with high-risk animals like bats that may carry the virus. The document provides details on the virus's pathogenesis, symptoms, subtypes, transmission methods, and the challenges it poses given its rapid multiplication and ability to evade immune responses.
Ebola Hemorrhagic Fever is a severe disease caused by the Ebola virus which originated in Africa. It spreads through contact with bodily fluids of infected humans or animals. Initial symptoms include fever, headache and muscle pain. Later symptoms include vomiting, diarrhea and internal/external bleeding. There is no approved vaccine or treatment, with supportive care being the standard. Prevention focuses on avoiding contact with infected patients and wildlife.
About EBOLA, Origin, types, Causes,Mode of Transmission, Symptoms, Treatment, Means to Help to Ease Symptoms, Teats & Diagnosis, Treatment & Drugs, Prevention, Vaccine Development,
Ebola virus is suspected to be zoonotic, transmitted from bats and primates to humans through contact with bodily fluids. It infects macrophages, causing them to release cytokines that produce symptoms like fever and vascular problems. This leads to small blood clots, disruption of coagulation, bleeding, and multi-organ failure. The incubation period is 2-21 days on average. Laboratory diagnosis involves non-specific tests like leukopenia and elevated liver enzymes, as well as specific tests detecting the virus's RNA, proteins, or antibodies.
Description about recent outbreak of Ebola virus in West African countries with history, pathogenesis, clinical signs and prevention measures of Filoviruses are presented in comprehensive manner.
This document summarizes key information about filoviruses Marburg virus and Ebola virus. It describes their family, genera, species, genome structure, morphology, replication, pathogenesis, outbreak history, transmission, vaccine development, recovery mechanisms, and suspected bat reservoirs. Major points include that filoviruses cause hemorrhagic fever outbreaks in Africa with high fatality rates through close contact transmission, and while experimental vaccines exist, recovery mechanisms remain unknown.
This document summarizes key information about the Ebola virus. It describes Ebola as an enveloped RNA virus that originated in Africa and is typically transmitted between humans through direct contact with bodily fluids of infected individuals. While fruit bats are believed to be the natural reservoir, humans can also contract the virus through contact with infected wildlife. The virus causes severe disease by directly infecting tissues and triggering immune dysregulation, hypovolemia, coagulopathy, and ultimately multi-organ failure. Mortality rates are high, ranging from 25-90% depending on the strain.
- Filoviruses like Ebola and Marburg viruses cause severe hemorrhagic fever in humans and non-human primates with high fatality rates. Though outbreaks are frequent, the natural reservoir of Ebola virus remains unclear.
- There are five species of Ebola virus (Zaire, Sudan, Reston, Ivory Coast, Bundibugyo) and Marburg virus. Ebola Zaire has the highest fatality rate of up to 90% while E. Reston has not caused death in humans.
- Transmission occurs through contact with bodily fluids of infected humans or animals. There is no approved treatment, though supportive care, vaccination research, and
Ebola virus disease is a severe and often fatal illness in humans caused by Ebola virus. The virus is transmitted through contact with infected wildlife like fruit bats or with bodily fluids of infected humans. Symptoms include sudden onset of fever, muscle pain and bleeding. While there is no approved vaccine, treatment focuses on rehydration and supportive care. Fruit bats are considered the natural reservoir of the virus in Africa.
This document provides information about Ebola virus disease, including its transmission, pathogenesis, symptoms, treatment, and prevention. Ebola is a zoonotic virus transmitted through contact with infected body fluids that causes hemorrhagic fever. It enters the body through mucous membranes or breaks in the skin. The virus then infects macrophages and endothelial cells, evading the immune system and causing systemic symptoms like fever, vomiting, and bleeding due to coagulopathy. Current treatment is supportive only, focusing on fluid replacement and symptom management.
Ebola virus disease is a severe and often fatal illness in humans that was first identified in 1976. The virus spreads through direct contact with body fluids from infected humans or animals. Early symptoms include fever, fatigue, and muscle pain that can progress to vomiting, diarrhea and internal bleeding. While there is no licensed treatment, supportive care such as rehydration can improve survival. The 2014-2015 outbreak in West Africa was the largest in history, resulting in over 23,000 cases and 9,600 deaths across multiple countries. Controlling the outbreak requires community engagement along with safe practices in healthcare settings and burials.
The document provides information on Ebola virus, including its history, outbreaks, transmission, symptoms, diagnosis and potential treatments. It discusses how Ebola was first identified in 1976 near the Ebola River in Africa. It causes severe hemorrhagic fever in humans with high mortality. While fruit bats are suspected to be the natural reservoir, transmission occurs between humans via contact with bodily fluids. Current efforts are focused on supportive care and experimental therapies like monoclonal antibodies, antivirals and immunomodulators until a vaccine is developed.
Ebola virus disease is a severe and often fatal disease caused by the Ebola virus. It first appeared in 1976 in simultaneous outbreaks in the Democratic Republic of Congo and Sudan. Ebola is categorized as a Category A bioterrorism agent due to its high potential to be used as a biological weapon because it can easily spread between humans and causes severe illness with high mortality rates. Signs and symptoms include fever, muscle pain, vomiting and bleeding. There is currently no cure, so treatment focuses on isolation, intensive care, and surveillance to prevent further spread.
This document provides an overview of computer viruses and methods for prevention and removal. It defines what a computer virus is and describes different types including boot sector viruses, file infector viruses, worms, macro viruses, and Trojan horses. Examples like Melissa and I Love You are given. Methods for manually removing some common viruses like New Folder.exe and Autorun.inf are outlined. The document stresses the importance of using antivirus software, regularly updating definitions, avoiding unsafe downloads and attachments, and making backups to help prevent and cure computer viruses.
Computer viruses are malicious software programs that can damage computers. They replicate and spread by infecting files. Different types of viruses exist, including memory resident viruses that hide in RAM, direct action viruses that infect files specified in AUTOEXEC.BAT, and boot sector viruses that infect the boot sector of hard disks. Anti-virus software detects, prevents, and removes viruses to protect computers and personal information from being damaged, stolen, or misused by viruses. Having anti-virus software installed provides various advantages like preventing viruses from formatting disks, deleting files, and slowing down computers.
This document provides information about computer viruses presented by a student group. It defines a computer virus, describes common types of viruses like Trojans and worms, and explains how viruses infect systems. The document also outlines signs of a virus attack, how to create a virus for educational purposes only, and methods for protecting against and removing viruses like installing antivirus software and deleting suspicious files. The presentation aims to educate users about computer viruses and promoting safe computing practices.
This document provides an overview of computer viruses and anti-virus software. It defines what viruses are and how they spread, describes common types of viruses. It then explains what anti-virus software is, how it works to detect and remove viruses, and lists some popular anti-virus programs. It concludes with a brief history of anti-virus software development from the late 1980s onward.
Viruses are non-living particles that can only reproduce inside host cells. They are smaller than bacteria and contain genetic material surrounded by a protein coat. Viruses come in various shapes and sizes and cause diseases like influenza, measles, HIV/AIDS, and some cancers. Edward Jenner developed the first vaccine for smallpox using a related cowpox virus. Viruses are identified based on their morphology, genetic material, presence of an envelope, capsid shape, host cell, and more. They exist in nature as parasites and depend on host cells for reproduction through lysogenic or lytic cycles.
Ebola virus causes a severe hemorrhagic fever in humans and nonhuman primates. It was first discovered in 1976 near the Ebola River in the Democratic Republic of Congo. There are 5 distinct subspecies of Ebola virus. The natural reservoir of the virus is unknown, but it is believed to be animal-borne, primarily occurring in Africa. Symptoms begin with fever, headache, and weakness and progress to vomiting, diarrhea, and hemorrhaging. The mortality rate can be as high as 90% and patients usually die from shock. There is no vaccine for Ebola virus.
Ebola virus disease was first identified in 1976 during outbreaks in Sudan and Zaire. It is caused by the Ebola virus and primarily affects humans and other primates. The virus spreads through direct contact with bodily fluids of infected individuals or animals. While its natural reservoir is unknown, fruit bats are suspected. There have been several outbreaks since 1976, with a major 2013-2014 outbreak in West Africa resulting in over 6,000 confirmed human deaths. Currently there is no approved vaccine or treatment, though supportive care is given to help fight secondary infections.
The document discusses the Ebola virus, which was first discovered in Africa in 1976. It notes that the current Ebola epidemic in West Africa has caused over 800 deaths so far. The virus has a high mortality rate of around 90% and there is currently no approved vaccine or cure. The virus is transmitted through direct contact with body fluids and has spread rapidly, causing global concern. Prevention methods include isolation of patients, proper medical training, sterilization of equipment, and avoiding direct contact with infected individuals or areas.
This document provides an overview of dengue fever. It begins with definitions of dengue fever and dengue virus. It describes the symptoms of dengue fever and characteristics of the Aedes mosquito, including its physical features, daytime biting habits, and egg laying in clean stagnant water. The life cycle of the Aedes mosquito is outlined, from egg to larva to pupa to adult. It explains how the Aedes mosquito transmits dengue virus between humans when taking blood meals. Pathogenesis and methods for laboratory diagnosis are briefly discussed. The document concludes with describing supportive treatments for dengue fever and emphasizing the importance of preventing Aedes mosquitoes from breeding to control the spread of the disease.
The document discusses Ebola Hemorrhagic Fever (EHF), a severe and often fatal disease that affects humans and nonhuman primates such as monkeys, gorillas and chimpanzees. EHF is caused by the Ebola virus, which was first discovered near the Ebola River in the Democratic Republic of Congo. There are five known subtypes of the Ebola virus, four of which can cause disease in humans, while the fifth causes disease in nonhuman primates. The virus is transmitted between humans through direct contact with bodily fluids such as blood, secretions, organs and semen.
This document provides an overview of hemorrhagic fevers focusing on filoviruses. It discusses the history and classification of hemorrhagic fever viruses including arenaviruses, bunyaviruses, flaviviruses, and filoviruses. Specific details are given about past outbreaks of Marburg virus in Europe and Africa and Ebola virus in several central African countries. The document also discusses transmission methods, reservoirs, morphology and structure, genome, and proteins of filoviruses.
This document discusses hemorrhagic fevers caused by filoviruses such as Marburg virus and Ebola virus. It provides a brief history of outbreaks caused by these viruses, describing the first recognized Ebola outbreak in 1976 which caused high mortality. It also summarizes key facts about filovirus morphology, structure, replication cycle, and transmission. The document outlines the reservoir, transmission mechanisms, and symptoms of Marburg and Ebola viruses.
The document discusses Ebola virus disease. It originated in Africa in 1976 and is a severe, often fatal disease in humans and primates. Symptoms include fever, headache, fatigue, sore throat, vomiting and diarrhea. The virus is transmitted through contact with infected bodily fluids or tissue. Diagnosis involves tests to detect antibodies, antigens or viral RNA. Prevention focuses on avoiding contact with infected individuals and animals and practicing good hygiene.
Ebola is a severe and often fatal viral disease that first appeared in 1976. It is caused by the Ebola virus and results in viral hemorrhagic fever. The virus likely originates from fruit bats and is transmitted between humans via contact with bodily fluids. Symptoms include fever, vomiting, and bleeding both internally and externally. There is currently no approved vaccine or treatment, though several are in development. Prevention relies on isolation of infected individuals and safe burial practices.
The document provides background information on diseases that have emerged throughout history, including Ebola. It discusses the 2014 Ebola outbreak in West Africa as the largest in history. It then describes a hypothetical scenario where one infected person arrives in Oakville, Canada, and uses a mathematical model to estimate how long it would take for the entire population to become infected in the absence of immunity or treatment.
Ebola virus disease is a severe and often fatal illness that causes hemorrhaging. Outbreaks primarily occur in central and west Africa near rainforests, with case fatality rates up to 90%. The natural reservoir of the Ebola virus is unknown but believed to be bats. People become infected through contact with infected wildlife or other humans. No licensed vaccine exists but several experimental vaccines are in development. Treatment focuses on rehydration and symptom management as there is no specific treatment.
The Ebola virus causes severe hemorrhagic fever in humans and non-human primates. While fruit bats are believed to be the natural reservoir, the full life cycle of the virus is not yet known. Ebola is transmitted through direct contact with body fluids like blood, and has an incubation period of 2 to 21 days. Symptoms start with fever and weakness and progress to internal and external bleeding. The virus replicates rapidly within host cells, destroying tissues and organs before being shed to infect new hosts.
The document discusses Ebola virus, which causes Ebola virus disease (EVD) or Ebola hemorrhagic fever (EHF) in humans and other primates. It describes how Ebola virus was first discovered near the Ebola River in Africa. There are five species of Ebola virus that can cause disease in humans. The document outlines the symptoms of EVD, which include fever, sore throat, muscle pain and can progress to vomiting, diarrhea, bleeding, and decreased organ function. It also discusses the epidemiology, statistics, clinical observations, treatment and prevention of Ebola virus disease.
Ebola virus disease is a severe and often fatal illness in humans that is transmitted through contact with infected animals or humans. The average fatality rate is around 50% and symptoms include fever, fatigue, muscle pain and bleeding. There are five strains of Ebola virus, with the Zaire strain being the most deadly. Ebola spreads through direct contact with bodily fluids of infected individuals but is not airborne. While there is no licensed vaccine or treatment, supportive care such as rehydration can improve survival rates.
The document discusses Ebola virus disease (EVD), including what it is, how it is transmitted, signs and symptoms, treatment, and preventative measures. EVD is a severe and often fatal disease in humans caused by infection with one of five Ebola virus strains. It spreads through direct contact with body fluids of infected humans or animals. Symptoms include fever, fatigue, vomiting and diarrhea which can be bloody. While there is no licensed treatment, recovery is possible with rehydration and treatment of specific symptoms. Preventative measures include avoiding contact with infected individuals or contaminated surfaces and objects.
This document discusses Ebola virus disease, including its history, symptoms, transmission, treatment and recommendations for prevention. It notes that Ebola is a severe and often fatal disease caused by Ebola virus. Fruit bats are believed to be the natural reservoir, infecting non-human primates which can then transmit the virus to humans through contact with bodily fluids. Major outbreaks have occurred in Central and West Africa. There is no vaccine or cure, so treatment focuses on relieving symptoms while the body fights the infection. Strict isolation protocols and proper hygiene practices are necessary to prevent further transmission.
The document provides an overview of Ebola virus disease (EVD), including its origins, transmission, signs and symptoms, diagnosis, treatment and recovery. Some key points:
- EVD first appeared in 1976 in simultaneous outbreaks in Sudan and Democratic Republic of Congo. The current 2014 outbreak in West Africa is the largest on record.
- The virus is transmitted through direct contact with body fluids of infected humans or animals. Early symptoms are nonspecific but progress to hemorrhagic fever, vomiting, diarrhea and organ failure.
- Diagnosis involves detecting the virus or antibodies in blood, with RT-PCR being the most sensitive test. There is no approved vaccine or treatment, so care is largely supportive
Ebola virus disease is caused by infection with one of five Ebolaviruses. It begins with flu-like symptoms and progresses to vomiting, diarrhea and decreased liver/kidney function. Bleeding occurs in 40-50% of cases. The disease spreads through contact with infected wildlife like fruit bats or through human-to-human transmission via bodily fluids. There is no approved vaccine or treatment, with fatality rates between 50-90%. Ongoing research focuses on understanding transmission and developing treatments.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
2. INTRODUCTION
- Ebola hemorrhagic fever: Named after a river
in the Congo where it was first found
- Often-fatal disease in humans and nonhuman
primates (monkeys, gorillas, and chimpanzees)
- Has appeared sporadically since its initial
recognition in 1976
- Mortality rate can reach 90%
3. -Family: Filoviridae
-Order: Mononegavirales
-5 distinct sub-species
-Cote d’Ivorie(Ivory Coast) ebolavirus
-Reston ebolavirus
-Sudan ebolavirus
-Zaire ebloavirus
-Bundibugyo ebolavirus
- Characteristics of Filoviruses:
- Filamentous form with a uniform diameter of approximately 80 nm
but display great variation in length.
- Nonsegmented negative-stranded RNA genome containing 7
structural and regulatory genes.
FAMILY AND ORDER
4. WHERE IS EBOLA FOUND
• Natural reservoir of the Ebola virus remains unknown.
• Zoonotic (animal-borne)
• Four of the 5 subtypes occur in an animal host native to Africa 1 occurs in Philippine monkeys .
• Origination: Africa...The virus is not known to be native to other continents, such as North
America.
6. Incubation period is 2-21 days . Symptoms are :-
Arthritic pain
Backache (low-back pain)
Chills
Diarrhea
Fatigue
Fever
Headache
Malaise (general feeling of being unwell)
Nausea
Sore throat
Vomiting
EARLY SYMPTOMS
7. LATE SYMPTOMS
Late symptoms include:
• Bleeding from eyes, ears, and nose
• Bleeding from the mouth and rectum (gastrointestinal bleeding)
• Depression
• Eye inflammation (conjunctivitis)
• Genital swelling (labia and scrotum)
• Increased feeling of pain in skin
• Rash over the entire body that often contains blood (hemorrhagic)
• Roof of mouth looks red
• Seizures, coma, delirium
As many as 90% of patients die from the disease. Patients usually die from shock rather than from blood
loss.
8. HOW IT WORKS
Threadlike Ebola virions bud from a cell. The
Ebola virus disables a cell's tetherin protein.
Tetherin: A human cellular protein which inhibits
retrovirus infection by preventing the diffusion of virus
particles after budding from infected cells
What is Ebola?:
According CDC, Ebola hemorrhagic fever is a deadly disease in both humans and nonhuman primates (monkeys and chimpanzees) caused by the Ebola virus;
characterized by high fever and severe internal bleeding; can be spread from person to person; is largely limited to Africa.
First found in the area of the Democratic Republic of the Congo, near the River Congo in 1976
mortality rate: 90%, that’s why is called deadly disease.
Highest fatality Rate is found in the Zaire sub-species.
The only reported cases in the U.S., Italy and England were all part of the Reston sub-species.
Natural reservoir of Ebola Virus still unknown until now.
Its Zoonotic
all 4 of 5 subtypes an animal Host in Africa
The virus itself stores its nucleic acid in the form of a +mRNA genome and serves as a means of delivery of that genome into cells it targets as an obligate parasite (Cannot live independently of the Host cell), and constitutes the infection. Once in the host's cell, the RNA strands undergo reverse transcription in the cytoplasm and are integrated into the host's genome, at which point the retroviral DNA is referred to as a provirus (A provirus is a virus genome that is integrated into the DNA of a host cell). It is difficult to detect the virus until it has infected the host.